Return to homepagePandemic Pact

Supporting the NIHR COVID-19 BioResource to enable comprehensive and immunophenotyping of affected individuals

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-201

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Prof. John Bradley, Prof. Ken Smith

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Cancer Unit

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The NIHR COVID-19 BioResource, part of the national NIHR BioResource, is recruiting a cohort of patients with suspected coronavirus infection to enable sample-based and data studies of COVID-19 disease, recovery and mental-health outcomes, and offer the opportunity for participants to be involved in future research studies. Biological samples from COVID-19 BioResource participants will be processed and analysed in specialist containment facilities in the newly opened Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID).